Patent · US Active

Spiroindoline compounds

US9096599B2 · kind B2 · utility

0Cited by

0References

17Claims

0Family size

Assignee

Intervet Inc. · US

Inventors

Christophe Pierre Alain Chassaing · Ingelheim am Rhein, DE
Sandra Koch · Bad Kreuznach, DE
Jürgen Lutz · Steinheim, DE

Key dates

Filing date	Aug 3, 2012
Grant date	Aug 4, 2015
Priority date	—
Expiry date	Aug 3, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P33/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This invention relates to novel spiroindoline compounds of formula (I) that are generally useful as medicaments, more specifically as medicaments for animals. The medicament can preferably be used for the treatment of helminth infections and the treatment of parasitosis, such as caused by helminth infections. This invention also relates to uses of the compounds to make medicaments and treatments comprising the administration of the compounds to animals in need of the treatments. This invention also relates to the preparation of said compounds. Moreover this invention relates to pharmaceutical compositions and kits comprising the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.